Regeneron Pharmaceuticals Inc (RGO)

Wow, absolutely great for the rats. I bet the FDA will be absolutely impressed.

You just said the CHM advises MHRA and MHRA makes the decision. But now you say the CHM sends the letter to the sponsor, not the MHRA. So the MHRA never finds out what the CHM recommended??

WTH! The PPS doesn’t make any sense.

PDIV likely to acquire GNCP ASSETS

Payable in share ot by loan most probably, at an INFLATED PRICE, so the lenders can get the mavimum value

Come on Lumb, disclose your transactions !!

You are late, supposed to be Q1 originally

Wash trading by the owner of djt is the only thing keeping the pps above 5 bucks.

I PROMISE YOU IF HE PULLS A R/S ON US,THIS THING WILL DIE SO FAST IT WILL NOT KNOW WHAT HIT IT.AND THAT IS A PROMISE.
STOCKS THAT PULL R/S ON ME,WHAT HAPPENED????MOST OF THEM ON EXPERT MARKET,OR BANKO,OR RIGHT BACK DOWN BEFORE THE R/S,OR THE VOLUMES GOT KILLED.ZERO INTEREST.IF HE THINKS OF A

I don’t recall what date it was but JT JB and Mr. Kramer were all on the spaces session. JB was there to talk about things that happened when he WAS the CEO. I asked a question about the 250+ million shares they previously talked about on the first spaces session and they clarified and confirmed tha

NO mention of the inflated OS. how are they going to handle it? RS or share buyback?

But even if they were separate entities (which they are not), if the MHRA asked the CHM to advise them on acceptance/refusal, and in response the CHM produces a letter indicating refusal for safety or lack of efficacy, would this relieve MHRA from an obligation to address the safety/efficacy issues

Let's see how this all works out, news sounds
good see what a few days brings!

Angel Founders Transfer More Than 10 Million Super-Voting Shares to Angel Mission Trust to Preserve Company’s Mission for GenerationsJuly 2, 2026 11:17 AM
Business WireAngel (NYSE: ANGX) – a media and technology company successfully pioneering a first of its kind audience-drive

Rubrik is Named a Leader in the 2026 Gartner® Magic Quadrant™July 2, 2026 11:17 AM
Business Wire Positioned as Leader and Furthest in Vision for Seven Consecutive Years Rubrik (NYSE: RBRK), the Security and AI Operations Company, has been named a Leader

Goldman Sachs Contributes to ‘Trump Accounts’ for Children of Its EmployeesJuly 2, 2026 11:30 AM
Business Wire Goldman Sachs to match federal seed contribution of $1,000 for eligible accounts, underscoring the importance of early savings and long-term investing to financial sec

I suggest you biotech investors look into RGNX. They have four late stage drugs, Abbvie partnership, etc. At $13 and change it remains a superior mid to long term investment. Do your own due diligence but Anavex is a dead dog.

hi sterling still kicking

A MARKET MAKER.A DILUTIVE MM

https://featureassets.gocomics.com/assets/cf79bf4014e4013fbf5d005056a9545d?optimizer=image&width=1200&quality=85

My normal human intelligence recognizes that this AI play as very intelligent move

$VISL - Vislink Technologies Strategic Overview and Defense Pivot.
https://www.youtube.com/watch?v=Tsq1qyxeetU

Zero!!! This will plunge below $5.00 in the month of July. Book it. This board isn’t comprised of realists. It’s a pump up chamber that ignore facts and what is really occurring. Which is no institutional confidence to move the price up. Pre-rev or not, this shouldn’t be below $10.

💯 Agree

OTCN? what is this